OTCMKTS:CGNH - CardioGenics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0175 0.00 (0.00 %) (As of 02/18/2019 01:05 PM ET)Previous Close$0.0150Today's Range$0.0142 - $0.0252-Week Range$0.0048 - $0.04Volume76,500 shsAverage Volume132,289 shsMarket Capitalization$1.68 millionP/E RatioN/ADividend YieldN/ABeta-2.05 ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada. Receive CGNH News and Ratings via Email Sign-up to receive the latest news and ratings for CGNH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Business services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CGNH Previous Symbol CUSIPN/A Webwww.cardiogenics.com Phone905-673-8501Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares96,051,000Market Cap$1.68 million OptionableNot Optionable CardioGenics (OTCMKTS:CGNH) Frequently Asked Questions What is CardioGenics' stock symbol? CardioGenics trades on the OTCMKTS under the ticker symbol "CGNH." Has CardioGenics been receiving favorable news coverage? Headlines about CGNH stock have been trending somewhat positive recently, according to InfoTrie. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. CardioGenics earned a coverage optimism score of 1.6 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near future. Who are some of CardioGenics' key competitors? Some companies that are related to CardioGenics include Janel (JANL), International Monetary Systems (ITNM), Live Current Media (LIVC), Sparta Commercial Services (SRCO), RightsCorp (RIHT), Prism Technologies Group (PRZM), Nsav (NSAV), Dale Jarrett Racing Adventure (TVMD), LiveWorld (LVWD), MoneyOnMobile (MOMT), MMRGlobal (MMRF), InterCloud Systems (ICLD), Coupon Express (CPXP), Hydrophi Technologies Group (HPTG) and Invictus Financial (IVFZF). Who are CardioGenics' key executives? CardioGenics' management team includes the folowing people: Dr. Yahya Abdul Gawad MB, Ch.B., M.D., MSc., Chief Exec. Officer and Director (Age 61)Mr. James A. Essex CA, MBA, Chief Financial Officer (Age 70)Ms. Linda J. Stering F.Inst.L.C.O., Sec. & Director (Age 58) How do I buy shares of CardioGenics? Shares of CGNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is CardioGenics' stock price today? One share of CGNH stock can currently be purchased for approximately $0.0175. How big of a company is CardioGenics? CardioGenics has a market capitalization of $1.68 million. What is CardioGenics' official website? The official website for CardioGenics is http://www.cardiogenics.com. How can I contact CardioGenics? CardioGenics' mailing address is 6295 Northam Drive Unit 8, Mississauga A6, L4V 1W8. The company can be reached via phone at 905-673-8501 or via email at [email protected] MarketBeat Community Rating for CardioGenics (OTCMKTS CGNH)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 48 (Vote Outperform)Underperform Votes: 29 (Vote Underperform)Total Votes: 77MarketBeat's community ratings are surveys of what our community members think about CardioGenics and other stocks. Vote "Outperform" if you believe CGNH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGNH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/18/2019 by MarketBeat.com StaffFeatured Article: How Do Investors Open a Backdoor Roth IRA?